ArticleCancer medicine2025

The Multi-Kinase Inhibitor GZD824 (Olverembatinib) Shows Pre-Clinical Efficacy in Endometrial Cancer.

Dongli Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.